New funding for the Global Fund supports equitable access to COVID-19 tools

US approves $3.5 billion in emergency funding for the Global Fund’s effort to fight the COVID-19 pandemic in low- and middle-income countries

How the European Commission's COVID-19 funding is being spent

Two recent EC reports describe how the funding pledge of €1.4 billion from Horizon 2020, the EU’s Research and Innovation Programme (2014-2020), has been spent

US$6 billion of new pledges announced by G7 leaders

G7 leaders announce additional funding commitments of over US$6 billion for COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator

The EIU COVID-19 Health Funding Tracker API

The EIU COVID-19 Health Funding Tracker data are now available to developers via Application Programming Interface (API)

ACT Accelerator to use the EIU as its official tracker

The EIU Covid-19 Health Funding Tracker presents interactive visualisation for the official ACT Accelerator Funding Commitment Tracker on WHO website

EIU report warns of significant delays in global coronavirus vaccine rollout

An Economist Intelligence Unit report estimates that more than 85 poor countries will not have widespread access to coronavirus vaccines before 2023

The promise of equitable access to vaccines is at risk

Recalling the response to past pandemics, WHO Director General warns of another moral failure

UNICEF to lead the delivery of COVID-19 vaccines to lower income countries

In partnership with Gavi, the WHO and PAHO, UNICEF plans to deliver vaccines to 92 countries

Gavi raises US$ 2 billion, but needs US$ 5 billion more in 2021 for vaccine procurement in lower income countries

Gavi, the Vaccine Alliance reaches goal of raising US$2 billion by the end of 2020

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week